Clinical Trial NCT05646563

Trial

NovelMed – NM8074

Clinical trial ID

NCT05646563

Drug name

---

Company:

NovelMed

Drug trade name

---

Phase of study

2

Current status

Not yet recruiting

Start

9/2023

Substance

monoclonal antibody

Research question

Mono vs eculizummab addon therapy to assess safety, efficacy and immunogenicity

Delivery method of drug

i.v.

Frequency

every 4 weeks/2 weeks

Clinical trial locations

tbd